367 related items for PubMed ID: 28158993
1. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
[Abstract] [Full Text] [Related]
2. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
Kidney Int; 2010 Aug 03; 78(3):296-302. PubMed ID: 20485332
[Abstract] [Full Text] [Related]
3. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
Pérez V, Ibernón M, López D, Pastor MC, Navarro M, Navarro-Muñoz M, Bonet J, Romero R.
PLoS One; 2014 Aug 03; 9(1):e87731. PubMed ID: 24498182
[Abstract] [Full Text] [Related]
4. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
Wang Y, Zheng C, Xu F, Liu Z.
Biochem Biophys Res Commun; 2016 Sep 23; 478(3):1147-52. PubMed ID: 27539323
[Abstract] [Full Text] [Related]
5. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
Li YH, Huang HC, Liu G, Zhang YK.
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 23; 36(2):135-8. PubMed ID: 15100729
[Abstract] [Full Text] [Related]
6. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
Eur J Clin Invest; 2015 Apr 23; 45(4):394-404. PubMed ID: 25682967
[Abstract] [Full Text] [Related]
7. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
Pediatr Nephrol; 2014 Aug 23; 29(8):1363-71. PubMed ID: 24263531
[Abstract] [Full Text] [Related]
8. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV, Vinogradov A, Brzhozovskiy AG, Kashirina DN, Indeykina MI, Bugrova AE, Lebedeva M, Moiseev S, Nikolaev EN, Kononikhin AS.
Int J Mol Sci; 2022 Oct 20; 23(20):. PubMed ID: 36293475
[Abstract] [Full Text] [Related]
9. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
An JN, Hyeon JS, Jung Y, Choi YW, Kim JH, Yang SH, Oh S, Kwon S, Lee SH, Cho JH, Park SH, Ha H, Kim DK, Lee JP, Hwang GS.
Sci Rep; 2019 Oct 11; 9(1):14707. PubMed ID: 31605028
[Abstract] [Full Text] [Related]
10. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM, da Silva CA, Monteiro MLGDR, Araújo LS, Rocha LP, Reis MBDR, Ramalho FS, Corrêa RRM, Silva MV, Reis MA, Machado JR.
PLoS One; 2019 Oct 11; 14(6):e0217569. PubMed ID: 31188898
[Abstract] [Full Text] [Related]
11. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Tong J, Xie J, Ren H, Liu J, Zhang W, Wei C, Xu J, Zhang W, Li X, Wang W, Lv D, He JC, Chen N.
PLoS One; 2015 Oct 11; 10(11):e0140453. PubMed ID: 26536600
[Abstract] [Full Text] [Related]
12. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
Navarro-Muñoz M, Ibernon M, Pérez V, Ara J, Espinal A, López D, Bonet J, Romero R.
Nephrol Dial Transplant; 2011 Dec 11; 26(12):3914-23. PubMed ID: 21414970
[Abstract] [Full Text] [Related]
13. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
Pediatr Nephrol; 2017 Aug 11; 32(8):1355-1361. PubMed ID: 28210837
[Abstract] [Full Text] [Related]
14. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2017 Oct 11; 32(10):1897-1905. PubMed ID: 28540445
[Abstract] [Full Text] [Related]
15. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
Huang Z, Zhang Y, Zhou J, Zhang Y.
Biomed Res Int; 2017 Oct 11; 2017():7298160. PubMed ID: 28246603
[Abstract] [Full Text] [Related]
16. Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome.
Wang Y, Zheng C, Wang X, Zuo K, Liu Z.
Mol Med Rep; 2017 Nov 11; 16(5):6276-6284. PubMed ID: 28849145
[Abstract] [Full Text] [Related]
17. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
Danilewicz M, Wagrowska-Danilewicz M.
Pol J Pathol; 1996 Nov 11; 47(4):209-14. PubMed ID: 9097714
[Abstract] [Full Text] [Related]
18. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM, Ezzat DA, Doudar NA, Adel M.
Iran J Kidney Dis; 2018 Mar 11; 12(2):107-111. PubMed ID: 29507273
[Abstract] [Full Text] [Related]
19. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST, Momeni B, Basiratnia M.
Saudi J Kidney Dis Transpl; 2010 Sep 11; 21(5):886-91. PubMed ID: 20814126
[Abstract] [Full Text] [Related]
20. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
Bu L, Mirocha J, Haas M.
Nephrol Dial Transplant; 2021 May 27; 36(6):1016-1022. PubMed ID: 32191308
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
